Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             20 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Are controlled trials of anticoagulation in children feasible? Male, Christoph

7 3 p. e193-e194
artikel
2 Can virtual reality change the paediatric health-care experience? Dunn, Amy L

7 3 p. e195
artikel
3 Catheter interventions: an unresolved clinical controversy Avgerinos, Efthymios D

7 3 p. e189
artikel
4 Catheter interventions: an unresolved clinical controversy – Authors' reply Notten, Pascale

7 3 p. e190
artikel
5 Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study Myers, Kasiani C

7 3 p. e238-e246
artikel
6 Comparison of international societal guidelines for the diagnosis of suspected pulmonary embolism during pregnancy Cohen, Stuart L

7 3 p. e247-e258
artikel
7 Correction to Lancet Haematol 2020; 7: e100–11
7 3 p. e191
artikel
8 First-line dasatinib discontinuation in chronic myeloid leukaemia: another step towards an “operational cure” Breccia, Massimo

7 3 p. e182-e183
artikel
9 Gene therapy 1·0 in haemophilia: effective and safe, but with many uncertainties Makris, Michael

7 3 p. e186-e188
artikel
10 Idiopathic multicentric Castleman disease: bringing order to chaos Leitch, Heather A

7 3 p. e180-e181
artikel
11 Imaging haemopoietic stem cells and microenvironment dynamics through transplantation Williams, Kirsten M

7 3 p. e259-e269
artikel
12 Interferon-α: alternative first- or second-line therapeutic option for polycythaemia vera Mascarenhas, John

7 3 p. e178-e179
artikel
13 Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study Kiladjian, Jean-Jacques

7 3 p. e226-e237
artikel
14 Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials van Rhee, Frits

7 3 p. e209-e217
artikel
15 Nursing impact on the CAR-T cell landscape McDermott, Kathleen

7 3 p. e192
artikel
16 Plasma cell leukaemia presenting as flower-shaped plasma cells mimicking adult T-cell leukaemia or lymphoma Shibusawa, Motoharu

7 3 p. e270
artikel
17 Polycythaemia vera, ruxolitinib, and hydroxyurea: where do we go now? Spivak, Jerry L

7 3 p. e184-e185
artikel
18 Rare diseases: not so out of the ordinary The Lancet Haematology,

7 3 p. e177
artikel
19 Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study Gisslinger, Heinz

7 3 p. e196-e208
artikel
20 Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial Kimura, Shinya

7 3 p. e218-e225
artikel
                             20 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland